TotalMarketCap

NewcelX

NCELNasdaq SwitzerlandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$16.404 M

$2.84 +12.25%

Close of 6 Nov 2026

As of 6 Nov 2026, NewcelX (NCEL) has a market capitalization of $16.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$8.30M

Loss-making

Shares outstanding

4,797,505

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #391Context TherapeuticsCNTX$17.2M
  2. #392Pasithea TherapeuticsKTTA$16.8M
  3. #393NewcelXNCEL$16.4M
  4. #394Psyence BiomedicalPBM$15.6M
  5. #395Citius PharmaceuticalsCTXR$15.4M

What if NewcelX were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,888,547

Per share 1,721,319× higher

Bitcoin $1.53T

$264,510.76

Per share 93,138× higher

Apple $5.02T

$868,364.15

Per share 305,762× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for NewcelX are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.